|1.||Ponka, Prem: 3 articles (07/2008 - 01/2003)|
|2.||Ponka, P: 3 articles (03/2005 - 01/2002)|
|3.||Buss, Joan L: 3 articles (01/2004 - 01/2003)|
|4.||Simůnek, T: 2 articles (03/2005 - 01/2002)|
|5.||Hrdina, R: 2 articles (03/2005 - 01/2002)|
|6.||Adamcová, M: 2 articles (03/2005 - 01/2002)|
|7.||Gersl, V: 2 articles (03/2005 - 01/2002)|
|8.||Klimtová, I: 2 articles (03/2005 - 01/2002)|
|9.||Neuzil, Jiri: 2 articles (01/2004 - 01/2003)|
|10.||Richardson, Des R: 1 article (07/2008)|
01/01/2002 - "Pyridoxal isonicotinoyl hydrazone (PIH) is a new tridentate Fe-chelating agent that should be very promising in many pathological states resulting from both an iron-overload and formation of free radicals. "
12/01/2001 - "Pyridoxal isonicotinoyl hydrazone (PIH) is an iron chelator with antioxidant activity, low toxicity and is useful in the experimental treatment of iron-overload diseases. "
04/01/1998 - "Pyridoxal isonicotinoyl hydrazone and its analogs: potential orally effective iron-chelating agents for the treatment of iron overload disease."
06/09/1983 - "Pyridoxal isonicotinoyl hydrazone (PIH) has recently been identified as a new iron chelating agent with a high degree of iron mobilizing activity in vitro and in vivo which makes this compound a candidate drug in the treatment of iron overload. "
11/15/1998 - "Pyridoxal isonicotinoyl hydrazone (PIH) has previously been studied for use in iron chelation therapy in iron-overload diseases. "
05/16/1997 - "Iron (Fe) chelators of the pyridoxal isonicotinoyl hydrazone (PIH) class may be useful agents to treat Fe overload disease and also cancer. "
01/15/2003 - "Analogs of pyridoxal isonicotinoyl hydrazone (PIH) are of interest as iron chelators for the treatment of secondary iron overload and cancer. "
06/01/2003 - "Examples of iron chelators that have shown promising anti-tumor activity (in various stages of development) include heterocyclic carboxaldehyde thiosemicarbazones, analogs of pyridoxal isonicotinoyl hydrazone, tachpyridine, O-trensox, desferrithiocin, and other natural and synthetic chelators. "
12/01/1995 - "Recent work with several analogues of the lipophilic Fe chelator, pyridoxal isonicotinoyl hydrazone (PIH), indicate that some of these ligands are considerably more efficient than DFO both in terms of their Fe chelation efficacy and at preventing 3H-thymidine incorporation by neuroblastoma (NB) cells (Richardson and Ponka, J Lab Clin Med 124:660, 1994). "
|7.||Iron Chelating Agents
|1.||Chelation Therapy (Therapy, Chelation)